Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

August 01, 2021; Volume 18,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Andrushkevich, Oleg M.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  2. Angelini, Daniela F.

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495

B

  1. Bai, Yuting

    1. You have access
      Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion
      Xin Wang, Zifei Pei, Aasma Hossain, Yuting Bai and Gong Chen
      Cancer Biology & Medicine August 2021, 18 (3) 860-874; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0499
  2. Bai, Zixuan

    1. You have access
      VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo
      Guangbo Kang, Min Hu, He Ren, Jiewen Wang, Xin Cheng, Ruowei Li, Bo Yuan, Yasmine Balan, Zixuan Bai and He Huang
      Cancer Biology & Medicine August 2021, 18 (3) 772-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0568
  3. Balan, Yasmine

    1. You have access
      VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo
      Guangbo Kang, Min Hu, He Ren, Jiewen Wang, Xin Cheng, Ruowei Li, Bo Yuan, Yasmine Balan, Zixuan Bai and He Huang
      Cancer Biology & Medicine August 2021, 18 (3) 772-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0568
  4. Balthasar, Joseph P.

    1. You have access
      Strategies to enhance monoclonal antibody uptake and distribution in solid tumors
      Brandon M. Bordeau and Joseph P. Balthasar
      Cancer Biology & Medicine August 2021, 18 (3) 649-664; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0704
  5. Battafarano, Giulia

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  6. Battistini, Luca

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  7. Bervitskiy, Anatoliy V.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  8. Bi, Minghong

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  9. Bogachev, Sergey S.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  10. Bordeau, Brandon M.

    1. You have access
      Strategies to enhance monoclonal antibody uptake and distribution in solid tumors
      Brandon M. Bordeau and Joseph P. Balthasar
      Cancer Biology & Medicine August 2021, 18 (3) 649-664; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0704

C

  1. Cai, Qingqing

    1. You have access
      Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
      Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
      Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
  2. Campese, Antonio Francesco

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  3. Cao, Shanbo

    1. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  4. Catizone, Angiolina

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  5. Cen, Xinan

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  6. Chan, Vicky TC

    1. You have access
      Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
      Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
      Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
  7. Chan, Vivian

    1. You have access
      Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
      Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
      Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
  8. Chen, Gong

    1. You have access
      Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion
      Xin Wang, Zifei Pei, Aasma Hossain, Yuting Bai and Gong Chen
      Cancer Biology & Medicine August 2021, 18 (3) 860-874; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0499
  9. Chen, Jin

    1. You have access
      Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
      Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
      Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430
  10. Chen, Meiting

    1. You have access
      Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
      Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
      Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
  11. Chen, Ru

    1. You have access
      Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030
      Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Ru Chen, Shaoming Wang, Kexin Sun, Hongmei Zeng, Wenqiang Wei and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 900-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0523
  12. Chen, Tao

    1. You have access
      FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma
      Tao Chen, Fei Wang, Shupei Wei, Yingjie Nie, Xiaotao Zheng, Yu Deng, Xubin Zhu, Yuezhen Deng, Nanshan Zhong and Chengzhi Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 665-674; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0389
  13. Chen, Xinfeng

    1. You have access
      NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
      Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290
  14. Chen, Zegeng

    1. You have access
      Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
      Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
      Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
  15. Chen, Zhendong

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  16. Cheng, Shuqun

    1. You have access
      Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
      Juxian Sun, Jiayi Wu, Chang Liu, Jie Shi, Yonggang Wei, Jianyin Zhou, Zhibo Zhang, Wan Yee Lau, Maolin Yan and Shuqun Cheng
      Cancer Biology & Medicine August 2021, 18 (3) 808-815; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0202
  17. Cheng, Xin

    1. You have access
      VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo
      Guangbo Kang, Min Hu, He Ren, Jiewen Wang, Xin Cheng, Ruowei Li, Bo Yuan, Yasmine Balan, Zixuan Bai and He Huang
      Cancer Biology & Medicine August 2021, 18 (3) 772-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0568
  18. Chernykh, Elena R.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  19. Cheung, Maggie

    1. You have access
      Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
      Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
      Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
  20. Chu, Tianqing

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  21. Cui, Shuzhong

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566
  22. Cui, Weiwen

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566

D

  1. De Cesaris, Paola

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  2. Del Fattore, Andrea

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  3. Deng, Changmi

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  4. Deng, Yiwen

    1. You have access
      Development and validation of a risk model for noninvasive detection of cancer in oral potentially malignant disorders using DNA image cytometry
      Chenxi Li, Yongmei Zhou, Yiwen Deng, Xuemin Shen, Linjun Shi and Wei Liu
      Cancer Biology & Medicine August 2021, 18 (3) 763-771; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0531
  5. Deng, Yu

    1. You have access
      FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma
      Tao Chen, Fei Wang, Shupei Wei, Yingjie Nie, Xiaotao Zheng, Yu Deng, Xubin Zhu, Yuezhen Deng, Nanshan Zhong and Chengzhi Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 665-674; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0389
  6. Deng, Yuezhen

    1. You have access
      FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma
      Tao Chen, Fei Wang, Shupei Wei, Yingjie Nie, Xiaotao Zheng, Yu Deng, Xubin Zhu, Yuezhen Deng, Nanshan Zhong and Chengzhi Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 665-674; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0389
  7. De Veirman, Kim

    1. You have access
      Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
      Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
      Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430
  8. Di Agostino, Silvia

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  9. Ding, Kai

    1. You have access
      Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
      Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
      Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430
  10. Di Stefano, Chiara

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  11. Dolgova, Evgeniya V.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  12. Dubatolova, Tatyana D.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511

E

  1. Efremov, Yaroslav R.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511

F

  1. Fang, Jian

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  2. Fang, Lin

    1. You have access
      Current research on circular RNAs and their potential clinical implications in breast cancer
      Diya Liu and Lin Fang
      Cancer Biology & Medicine August 2021, 18 (3) 635-648; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0275
  3. Fang, Shuai

    1. You have access
      LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients
      Haihua Tian, Jinchang Pan, Shuai Fang, Chengwei Zhou, Hui Tian, Jinxian He, Weiyu Shen, Xiaodan Meng, Xiaofeng Jin and Zhaohui Gong
      Cancer Biology & Medicine August 2021, 18 (3) 675-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0136
  4. Fang, Shuxian

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566
  5. Fang, Xiaojie

    1. You have access
      Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
      Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
      Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
  6. Feng, Xiaoli

    1. You have access
      A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
      Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 734-749; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0397
  7. Filippini, Antonio

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  8. Fontanella, Rosaria A.

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  9. Franceschini, Gianluca

    1. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  10. Fu, Rong

    1. You have access
      Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
      Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
      Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430

G

  1. Gao, Songlin

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
  2. Gao, Yuhuan

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  3. Gong, Zhaohui

    1. You have access
      LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients
      Haihua Tian, Jinchang Pan, Shuai Fang, Chengwei Zhou, Hui Tian, Jinxian He, Weiyu Shen, Xiaodan Meng, Xiaofeng Jin and Zhaohui Gong
      Cancer Biology & Medicine August 2021, 18 (3) 675-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0136
  4. Guerrera, Gisella

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  5. Guo, Qisen

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212

H

  1. Han, Baohui

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  2. Han, Cuicui

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  3. Han, Sen

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  4. He, Jianxia

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  5. He, Jie

    1. You have access
      A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
      Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 734-749; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0397
    2. You have access
      Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030
      Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Ru Chen, Shaoming Wang, Kexin Sun, Hongmei Zeng, Wenqiang Wei and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 900-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0523
  6. He, Jinfu

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566
  7. He, Jinxian

    1. You have access
      LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients
      Haihua Tian, Jinchang Pan, Shuai Fang, Chengwei Zhou, Hui Tian, Jinxian He, Weiyu Shen, Xiaodan Meng, Xiaofeng Jin and Zhaohui Gong
      Cancer Biology & Medicine August 2021, 18 (3) 675-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0136
  8. He, Qingjun

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566
  9. He, Yongqiao

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  10. Hong, Zhixian

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  11. Hossain, Aasma

    1. You have access
      Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion
      Xin Wang, Zifei Pei, Aasma Hossain, Yuting Bai and Gong Chen
      Cancer Biology & Medicine August 2021, 18 (3) 860-874; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0499
  12. Hu, Min

    1. You have access
      VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo
      Guangbo Kang, Min Hu, He Ren, Jiewen Wang, Xin Cheng, Ruowei Li, Bo Yuan, Yasmine Balan, Zixuan Bai and He Huang
      Cancer Biology & Medicine August 2021, 18 (3) 772-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0568
  13. Hu, Nanlin

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
    2. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  14. Hu, Yi

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  15. Huang, He

    1. You have access
      VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo
      Guangbo Kang, Min Hu, He Ren, Jiewen Wang, Xin Cheng, Ruowei Li, Bo Yuan, Yasmine Balan, Zixuan Bai and He Huang
      Cancer Biology & Medicine August 2021, 18 (3) 772-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0568
    2. You have access
      Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
      Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
      Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
  16. Huang, Jianbin

    1. You have access
      A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
      Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 734-749; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0397
  17. Huang, Laiqiang

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566
  18. Huang, Lan

    1. You have access
      NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
      Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290

J

  1. Jia, Weihua

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  2. Jia, Xiaodong

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  3. Jia, Yijing

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  4. Jia, Zhuqing

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
  5. Jiang, Fengjuan

    1. You have access
      Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
      Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
      Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430
  6. Jiang, Shengwei

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566
  7. Jin, Xiaofeng

    1. You have access
      LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients
      Haihua Tian, Jinchang Pan, Shuai Fang, Chengwei Zhou, Hui Tian, Jinxian He, Weiyu Shen, Xiaodan Meng, Xiaofeng Jin and Zhaohui Gong
      Cancer Biology & Medicine August 2021, 18 (3) 675-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0136
  8. Jing, Hongmei

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413

K

  1. Kang, Guangbo

    1. You have access
      VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo
      Guangbo Kang, Min Hu, He Ren, Jiewen Wang, Xin Cheng, Ruowei Li, Bo Yuan, Yasmine Balan, Zixuan Bai and He Huang
      Cancer Biology & Medicine August 2021, 18 (3) 772-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0568
  2. Kirikovich, Svetlana S.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  3. Kisaretova, Polina E.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  4. Kwok, Carol CH

    1. You have access
      Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
      Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
      Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241

L

  1. Lai, Kwai T

    1. You have access
      Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
      Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
      Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
  2. Lau, Thomas KH

    1. You have access
      Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
      Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
      Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
  3. Lau, Wan Yee

    1. You have access
      Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
      Juxian Sun, Jiayi Wu, Chang Liu, Jie Shi, Yonggang Wei, Jianyin Zhou, Zhibo Zhang, Wan Yee Lau, Maolin Yan and Shuqun Cheng
      Cancer Biology & Medicine August 2021, 18 (3) 808-815; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0202
  4. Lei, Shaoyuan

    1. You have access
      Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030
      Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Ru Chen, Shaoming Wang, Kexin Sun, Hongmei Zeng, Wenqiang Wei and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 900-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0523
  5. Lei, Yuanyuan

    1. You have access
      A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
      Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 734-749; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0397
  6. Levites, Evgeniy V.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  7. Li, Chenxi

    1. You have access
      Development and validation of a risk model for noninvasive detection of cancer in oral potentially malignant disorders using DNA image cytometry
      Chenxi Li, Yongmei Zhou, Yiwen Deng, Xuemin Shen, Linjun Shi and Wei Liu
      Cancer Biology & Medicine August 2021, 18 (3) 763-771; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0531
  8. Li, Danhua

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  9. Li, Fangfang

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  10. Li, Kai

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  11. Li, Leung

    1. You have access
      Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
      Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
      Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
  12. Li, Lijuan

    1. You have access
      Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
      Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
      Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430
  13. Li, Mingzhou

    1. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  14. Li, Qiao

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
  15. Li, Qing

    1. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  16. Li, Ruowei

    1. You have access
      VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo
      Guangbo Kang, Min Hu, He Ren, Jiewen Wang, Xin Cheng, Ruowei Li, Bo Yuan, Yasmine Balan, Zixuan Bai and He Huang
      Cancer Biology & Medicine August 2021, 18 (3) 772-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0568
  17. Li, Xiaoqian

    1. You have access
      Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
      Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
      Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
  18. Li, Zengjun

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  19. Li, Zhiming

    1. You have access
      Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
      Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
      Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
  20. Liangpunsakul, Suthat

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  21. Liao, Quanxing

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566
  22. Liao, Ying

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  23. Lin, Tongyu

    1. You have access
      Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
      Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
      Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
  24. Lippi, Giuseppe

    1. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  25. Liu, Aichun

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  26. Liu, Chang

    1. You have access
      Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
      Juxian Sun, Jiayi Wu, Chang Liu, Jie Shi, Yonggang Wei, Jianyin Zhou, Zhibo Zhang, Wan Yee Lau, Maolin Yan and Shuqun Cheng
      Cancer Biology & Medicine August 2021, 18 (3) 808-815; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0202
  27. Liu, Chengming

    1. You have access
      A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
      Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 734-749; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0397
  28. Liu, Diya

    1. You have access
      Current research on circular RNAs and their potential clinical implications in breast cancer
      Diya Liu and Lin Fang
      Cancer Biology & Medicine August 2021, 18 (3) 635-648; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0275
  29. Liu, Hui

    1. You have access
      Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
      Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
      Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430
    2. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  30. Liu, Lihong

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  31. Liu, Quan

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  32. Liu, Shasha

    1. You have access
      NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
      Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290
  33. Liu, Wei

    1. You have access
      Development and validation of a risk model for noninvasive detection of cancer in oral potentially malignant disorders using DNA image cytometry
      Chenxi Li, Yongmei Zhou, Yiwen Deng, Xuemin Shen, Linjun Shi and Wei Liu
      Cancer Biology & Medicine August 2021, 18 (3) 763-771; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0531
  34. Liu, Zhaoyun

    1. You have access
      Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
      Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
      Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430
  35. Lu, Jun

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  36. Lu, Shanshan

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  37. Lu, Yinying

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  38. Luo, Jianmin

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  39. Luo, Yang

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
    2. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418

M

  1. Ma, Fei

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
    2. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  2. Ma, Shaohua

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566
  3. Mao, Shuangshuang

    1. You have access
      A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
      Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 734-749; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0397
  4. Marta, Gustavo N.

    1. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  5. Meng, Xiaodan

    1. You have access
      LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients
      Haihua Tian, Jinchang Pan, Shuai Fang, Chengwei Zhou, Hui Tian, Jinxian He, Weiyu Shen, Xiaodan Meng, Xiaofeng Jin and Zhaohui Gong
      Cancer Biology & Medicine August 2021, 18 (3) 675-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0136
  6. Mishinov, Sergey V.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  7. Mo, Frankie KF

    1. You have access
      Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
      Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
      Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
  8. Moysak, Galina I.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511

N

  1. Naito, Yoichi

    1. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  2. Neckers, Leonard M.

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  3. Nie, Yingjie

    1. You have access
      FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma
      Tao Chen, Fei Wang, Shupei Wei, Yingjie Nie, Xiaotao Zheng, Yu Deng, Xubin Zhu, Yuezhen Deng, Nanshan Zhong and Chengzhi Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 665-674; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0389

O

  1. O’Connor, O. A.

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  2. Orlandi, Armando

    1. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  3. Osman, Mohammed A.

    1. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  4. Ostanin, Alexandr A.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511

P

  1. Padula, Fabrizio

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  2. Pan, Fei

    1. You have access
      Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
      Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
      Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
  3. Pan, Jinchang

    1. You have access
      LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients
      Haihua Tian, Jinchang Pan, Shuai Fang, Chengwei Zhou, Hui Tian, Jinxian He, Weiyu Shen, Xiaodan Meng, Xiaofeng Jin and Zhaohui Gong
      Cancer Biology & Medicine August 2021, 18 (3) 675-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0136
  4. Pan, Yisheng

    1. You have access
      A breakthrough in liver regeneration for treatment of liver cancer
      Hao Xu, Yisheng Pan and Ning Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 631-634; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0293
  5. Pang, Elizabeth

    1. You have access
      Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
      Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
      Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
  6. Pei, Zifei

    1. You have access
      Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion
      Xin Wang, Zifei Pei, Aasma Hossain, Yuting Bai and Gong Chen
      Cancer Biology & Medicine August 2021, 18 (3) 860-874; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0499
  7. Peng, Fengping

    1. You have access
      Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
      Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
      Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430
  8. Potter, Ekaterina A.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  9. Proskurina, Anastasia S.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511

Q

  1. Qin, Guohui

    1. You have access
      NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
      Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290

R

  1. Ren, He

    1. You have access
      VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo
      Guangbo Kang, Min Hu, He Ren, Jiewen Wang, Xin Cheng, Ruowei Li, Bo Yuan, Yasmine Balan, Zixuan Bai and He Huang
      Cancer Biology & Medicine August 2021, 18 (3) 772-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0568
  2. Ren, Quanguang

    1. You have access
      Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
      Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
      Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
  3. Riccioli, Anna

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  4. Ritter, Genrikh S.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  5. Romanenko, Margarita V.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  6. Romaschenko, Alexandr V.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  7. Roshchin, Stanislav Yu.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  8. Rzaev, Jamil A.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511

S

  1. Safadi, Rifaat

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  2. Shao, Qing

    1. You have access
      Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
      Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
      Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430
  3. Shao, Yang

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
  4. Shen, Jing

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  5. Shen, Weiyu

    1. You have access
      LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients
      Haihua Tian, Jinchang Pan, Shuai Fang, Chengwei Zhou, Hui Tian, Jinxian He, Weiyu Shen, Xiaodan Meng, Xiaofeng Jin and Zhaohui Gong
      Cancer Biology & Medicine August 2021, 18 (3) 675-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0136
  6. Shen, Xuemin

    1. You have access
      Development and validation of a risk model for noninvasive detection of cancer in oral potentially malignant disorders using DNA image cytometry
      Chenxi Li, Yongmei Zhou, Yiwen Deng, Xuemin Shen, Linjun Shi and Wei Liu
      Cancer Biology & Medicine August 2021, 18 (3) 763-771; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0531
  7. Shi, Jianhua

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  8. Shi, Jie

    1. You have access
      Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
      Juxian Sun, Jiayi Wu, Chang Liu, Jie Shi, Yonggang Wei, Jianyin Zhou, Zhibo Zhang, Wan Yee Lau, Maolin Yan and Shuqun Cheng
      Cancer Biology & Medicine August 2021, 18 (3) 808-815; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0202
  9. Shi, Linjun

    1. You have access
      Development and validation of a risk model for noninvasive detection of cancer in oral potentially malignant disorders using DNA image cytometry
      Chenxi Li, Yongmei Zhou, Yiwen Deng, Xuemin Shen, Linjun Shi and Wei Liu
      Cancer Biology & Medicine August 2021, 18 (3) 763-771; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0531
  10. Si, Yiran

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
  11. Sideri, Silvia

    1. You have access
      CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
      Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli
      Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
  12. Song, Jia

    1. You have access
      Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
      Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
      Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430
  13. Song, Yuhuan

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  14. Su, Hang

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  15. Su, Liping

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  16. Suen, Joyce JS

    1. You have access
      Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
      Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
      Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
  17. Sun, Juxian

    1. You have access
      Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
      Juxian Sun, Jiayi Wu, Chang Liu, Jie Shi, Yonggang Wei, Jianyin Zhou, Zhibo Zhang, Wan Yee Lau, Maolin Yan and Shuqun Cheng
      Cancer Biology & Medicine August 2021, 18 (3) 808-815; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0202
  18. Sun, Kexin

    1. You have access
      Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030
      Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Ru Chen, Shaoming Wang, Kexin Sun, Hongmei Zeng, Wenqiang Wei and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 900-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0523
  19. Sun, Nan

    1. You have access
      A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
      Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 734-749; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0397
  20. Sun, Tingting

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463

T

  1. Tang, Hongsheng

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566
  2. Taranov, Oleg S.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  3. Tian, Haihua

    1. You have access
      LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients
      Haihua Tian, Jinchang Pan, Shuai Fang, Chengwei Zhou, Hui Tian, Jinxian He, Weiyu Shen, Xiaodan Meng, Xiaofeng Jin and Zhaohui Gong
      Cancer Biology & Medicine August 2021, 18 (3) 675-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0136
  4. Tian, Hui

    1. You have access
      LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients
      Haihua Tian, Jinchang Pan, Shuai Fang, Chengwei Zhou, Hui Tian, Jinxian He, Weiyu Shen, Xiaodan Meng, Xiaofeng Jin and Zhaohui Gong
      Cancer Biology & Medicine August 2021, 18 (3) 675-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0136
  5. Tian, Ying

    1. You have access
      Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
      Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
      Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314

V

  1. Vanderkerken, Karin

    1. You have access
      Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
      Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
      Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430

W

  1. Wang, Dong

    1. You have access
      NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
      Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290
  2. Wang, Fang

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  3. Wang, Fei

    1. You have access
      FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma
      Tao Chen, Fei Wang, Shupei Wei, Yingjie Nie, Xiaotao Zheng, Yu Deng, Xubin Zhu, Yuezhen Deng, Nanshan Zhong and Chengzhi Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 665-674; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0389
  4. Wang, Feng

    1. You have access
      NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
      Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290
  5. Wang, Jiayu

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
    2. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  6. Wang, Jiewen

    1. You have access
      VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo
      Guangbo Kang, Min Hu, He Ren, Jiewen Wang, Xin Cheng, Ruowei Li, Bo Yuan, Yasmine Balan, Zixuan Bai and He Huang
      Cancer Biology & Medicine August 2021, 18 (3) 772-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0568
  7. Wang, Jing

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  8. Wang, Jingwen

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  9. Wang, Liping

    1. You have access
      NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
      Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290
  10. Wang, Quanshun

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  11. Wang, Shaoming

    1. You have access
      Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030
      Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Ru Chen, Shaoming Wang, Kexin Sun, Hongmei Zeng, Wenqiang Wei and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 900-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0523
  12. Wang, Shuye

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  13. Wang, Sihui

    1. You have access
      A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
      Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 734-749; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0397
  14. Wang, Tongmin

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  15. Wang, Wenmiao

    1. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  16. Wang, Xin

    1. You have access
      Transcription factor-based gene therapy to treat glioblastoma through direct neuronal conversion
      Xin Wang, Zifei Pei, Aasma Hossain, Yuting Bai and Gong Chen
      Cancer Biology & Medicine August 2021, 18 (3) 860-874; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0499
  17. Wang, Xinfeng

    1. You have access
      A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
      Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 734-749; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0397
  18. Wang, Xiuwen

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  19. Wang, Xue

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
    2. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  20. Wang, Yong

    1. You have access
      NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
      Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290
  21. Wang, Zhao

    1. You have access
      Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
      Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
      Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
  22. Wei, Shupei

    1. You have access
      FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma
      Tao Chen, Fei Wang, Shupei Wei, Yingjie Nie, Xiaotao Zheng, Yu Deng, Xubin Zhu, Yuezhen Deng, Nanshan Zhong and Chengzhi Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 665-674; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0389
  23. Wei, Wenqiang

    1. You have access
      Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030
      Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Ru Chen, Shaoming Wang, Kexin Sun, Hongmei Zeng, Wenqiang Wei and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 900-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0523
  24. Wei, Yonggang

    1. You have access
      Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
      Juxian Sun, Jiayi Wu, Chang Liu, Jie Shi, Yonggang Wei, Jianyin Zhou, Zhibo Zhang, Wan Yee Lau, Maolin Yan and Shuqun Cheng
      Cancer Biology & Medicine August 2021, 18 (3) 808-815; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0202
  25. Wong, Kwan H

    1. You have access
      Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
      Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
      Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
  26. Wu, Dawei

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  27. Wu, Huijuan

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  28. Wu, Jiayi

    1. You have access
      Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
      Juxian Sun, Jiayi Wu, Chang Liu, Jie Shi, Yonggang Wei, Jianyin Zhou, Zhibo Zhang, Wan Yee Lau, Maolin Yan and Shuqun Cheng
      Cancer Biology & Medicine August 2021, 18 (3) 808-815; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0202
  29. Wu, Ziyi

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464

X

  1. Xu, Binghe

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
    2. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  2. Xu, Hao

    1. You have access
      A breakthrough in liver regeneration for treatment of liver cancer
      Hao Xu, Yisheng Pan and Ning Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 631-634; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0293
  3. Xu, Wanping

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  4. Xue, Wenqiong

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464

Y

  1. Yan, Maolin

    1. You have access
      Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
      Juxian Sun, Jiayi Wu, Chang Liu, Jie Shi, Yonggang Wei, Jianyin Zhou, Zhibo Zhang, Wan Yee Lau, Maolin Yan and Shuqun Cheng
      Cancer Biology & Medicine August 2021, 18 (3) 808-815; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0202
  2. Yan, Siyang

    1. You have access
      Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
      Fengjuan Jiang, Hui Liu, Fengping Peng, Zhaoyun Liu, Kai Ding, Jia Song, Lijuan Li, Jin Chen, Qing Shao, Siyang Yan, Kim De Veirman, Karin Vanderkerken and Rong Fu
      Cancer Biology & Medicine August 2021, 18 (3) 721-733; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0430
  3. Yang, Dawei

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  4. Yang, Xiansheng

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566
  5. Yang, Xianzi

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566
  6. Yang, Xinrui

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  7. Yang, Zhihong

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  8. Yao, Yuyi

    1. You have access
      Modified R-CODOX-M/IVAC chemotherapy regimens in Chinese patients with untreated sporadic Burkitt lymphoma
      Meiting Chen, Zhao Wang, Xiaojie Fang, Yuyi Yao, Quanguang Ren, Zegeng Chen, Ying Tian, Fei Pan, Xiaoqian Li, Zhiming Li, Qingqing Cai, He Huang and Tongyu Lin
      Cancer Biology & Medicine August 2021, 18 (3) 833-840; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0314
  9. Yeo, Winnie

    1. You have access
      Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
      Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
      Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
  10. Yip, Christopher CH

    1. You have access
      Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
      Winnie Yeo, Leung Li, Thomas KH Lau, Kwai T Lai, Vicky TC Chan, Kwan H Wong, Christopher CH Yip, Elizabeth Pang, Maggie Cheung, Vivian Chan, Carol CH Kwok, Joyce JS Suen and Frankie KF Mo
      Cancer Biology & Medicine August 2021, 18 (3) 825-832; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0241
  11. Yu, Yan

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  12. Yuan, Bo

    1. You have access
      VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo
      Guangbo Kang, Min Hu, He Ren, Jiewen Wang, Xin Cheng, Ruowei Li, Bo Yuan, Yasmine Balan, Zixuan Bai and He Huang
      Cancer Biology & Medicine August 2021, 18 (3) 772-787; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0568
  13. Yuan, Leilei

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  14. Yuan, Peng

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
    2. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  15. Yuan, Shengxian

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  16. Yue, Dongli

    1. You have access
      NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
      Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290
  17. Yue, Jian

    1. You have access
      Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
      Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
      Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
    2. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418

Z

  1. Zavyalov, Evgeniy L.

    1. You have access
      Efficacy of the new therapeutic approach in curing malignant neoplasms on the model of human glioblastoma
      Evgeniya V. Dolgova, Oleg M. Andrushkevich, Polina E. Kisaretova, Anastasia S. Proskurina, Genrikh S. Ritter, Tatyana D. Dubatolova, Margarita V. Romanenko, Oleg S. Taranov, Yaroslav R. Efremov, Evgeniy L. Zavyalov, Alexandr V. Romaschenko, Sergey V. Mishinov, Svetlana S. Kirikovich, Evgeniy V. Levites, Ekaterina A. Potter, Alexandr A. Ostanin, Elena R. Chernykh, Stanislav Yu. Roshchin, Anatoliy V. Bervitskiy, Galina I. Moysak, Jamil A. Rzaev and Sergey S. Bogachev
      Cancer Biology & Medicine August 2021, 18 (3) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0511
  2. Zeng, Hongmei

    1. You have access
      Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030
      Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Ru Chen, Shaoming Wang, Kexin Sun, Hongmei Zeng, Wenqiang Wei and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 900-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0523
  3. Zeng, Lisi

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566
  4. Zeng, Zhen

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  5. Zhang, Helong

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  6. Zhang, Huanyu

    1. You have access
      NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
      Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290
  7. Zhang, Huilai

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  8. Zhang, Jiangbo

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  9. Zhang, Ning

    1. You have access
      A breakthrough in liver regeneration for treatment of liver cancer
      Hao Xu, Yisheng Pan and Ning Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 631-634; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0293
  10. Zhang, Pin

    1. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  11. Zhang, Siwei

    1. You have access
      Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030
      Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Ru Chen, Shaoming Wang, Kexin Sun, Hongmei Zeng, Wenqiang Wei and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 900-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0523
  12. Zhang, Tengfei

    1. You have access
      NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
      Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290
  13. Zhang, Ting

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  14. Zhang, Wei

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  15. Zhang, Wenli

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  16. Zhang, Xiaochun

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
  17. Zhang, Yi

    1. You have access
      NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
      Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290
  18. Zhang, Zhibo

    1. You have access
      Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
      Juxian Sun, Jiayi Wu, Chang Liu, Jie Shi, Yonggang Wei, Jianyin Zhou, Zhibo Zhang, Wan Yee Lau, Maolin Yan and Shuqun Cheng
      Cancer Biology & Medicine August 2021, 18 (3) 808-815; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0202
  19. Zhao, Haoran

    1. You have access
      Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
      Lisi Zeng, Quanxing Liao, Haoran Zhao, Shengwei Jiang, Xianzi Yang, Hongsheng Tang, Qingjun He, Xiansheng Yang, Shuxian Fang, Jinfu He, Weiwen Cui, Laiqiang Huang, Shaohua Ma and Shuzhong Cui
      Cancer Biology & Medicine August 2021, 18 (3) 750-762; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0566
  20. Zhao, Song

    1. You have access
      NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
      Dongli Yue, Shasha Liu, Tengfei Zhang, Yong Wang, Guohui Qin, Xinfeng Chen, Huanyu Zhang, Dong Wang, Lan Huang, Feng Wang, Liping Wang, Song Zhao and Yi Zhang
      Cancer Biology & Medicine August 2021, 18 (3) 705-720; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0290
  21. Zheng, Meiqi

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  22. Zheng, Rongshou

    1. You have access
      Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030
      Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Ru Chen, Shaoming Wang, Kexin Sun, Hongmei Zeng, Wenqiang Wei and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 900-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0523
  23. Zheng, Sufei

    1. You have access
      A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
      Chengming Liu, Sihui Wang, Sufei Zheng, Xinfeng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun and Jie He
      Cancer Biology & Medicine August 2021, 18 (3) 734-749; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0397
  24. Zheng, Xiaotao

    1. You have access
      FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma
      Tao Chen, Fei Wang, Shupei Wei, Yingjie Nie, Xiaotao Zheng, Yu Deng, Xubin Zhu, Yuezhen Deng, Nanshan Zhong and Chengzhi Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 665-674; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0389
  25. Zhong, Nanshan

    1. You have access
      FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma
      Tao Chen, Fei Wang, Shupei Wei, Yingjie Nie, Xiaotao Zheng, Yu Deng, Xubin Zhu, Yuezhen Deng, Nanshan Zhong and Chengzhi Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 665-674; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0389
  26. Zhou, Chengwei

    1. You have access
      LncRNA DPP10-AS1 promotes malignant processes through epigenetically activating its cognate gene DPP10 and predicts poor prognosis in lung cancer patients
      Haihua Tian, Jinchang Pan, Shuai Fang, Chengwei Zhou, Hui Tian, Jinxian He, Weiyu Shen, Xiaodan Meng, Xiaofeng Jin and Zhaohui Gong
      Cancer Biology & Medicine August 2021, 18 (3) 675-692; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0136
  27. Zhou, Chengzhi

    1. You have access
      FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma
      Tao Chen, Fei Wang, Shupei Wei, Yingjie Nie, Xiaotao Zheng, Yu Deng, Xubin Zhu, Yuezhen Deng, Nanshan Zhong and Chengzhi Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 665-674; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0389
  28. Zhou, Daobin

    1. You have access
      The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
      Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yuhuan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, O. A. O’Connor and Daobin Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 841-848; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0413
  29. Zhou, Jianyin

    1. You have access
      Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
      Juxian Sun, Jiayi Wu, Chang Liu, Jie Shi, Yonggang Wei, Jianyin Zhou, Zhibo Zhang, Wan Yee Lau, Maolin Yan and Shuqun Cheng
      Cancer Biology & Medicine August 2021, 18 (3) 808-815; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0202
  30. Zhou, Ting

    1. You have access
      Epstein-Barr virus DNA loads in the peripheral blood cells predict the survival of locoregionally-advanced nasopharyngeal carcinoma patients
      Yongqiao He, Dawei Yang, Ting Zhou, Wenqiong Xue, Jiangbo Zhang, Fangfang Li, Fang Wang, Tongmin Wang, Ziyi Wu, Ying Liao, Meiqi Zheng, Changmi Deng, Danhua Li, Yijing Jia, Leilei Yuan, Wenli Zhang and Weihua Jia
      Cancer Biology & Medicine August 2021, 18 (3) 888-899; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0464
  31. Zhou, Weiping

    1. You have access
      Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy
      Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
      Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262
  32. Zhou, Yongmei

    1. You have access
      Development and validation of a risk model for noninvasive detection of cancer in oral potentially malignant disorders using DNA image cytometry
      Chenxi Li, Yongmei Zhou, Yiwen Deng, Xuemin Shen, Linjun Shi and Wei Liu
      Cancer Biology & Medicine August 2021, 18 (3) 763-771; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0531
  33. Zhu, Anjie

    1. You have access
      Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
      Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi
      Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418
  34. Zhu, Xubin

    1. You have access
      FGFR/RACK1 interacts with MDM2, promotes P53 degradation, and inhibits cell senescence in lung squamous cell carcinoma
      Tao Chen, Fei Wang, Shupei Wei, Yingjie Nie, Xiaotao Zheng, Yu Deng, Xubin Zhu, Yuezhen Deng, Nanshan Zhong and Chengzhi Zhou
      Cancer Biology & Medicine August 2021, 18 (3) 665-674; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0389
  35. Zhuang, Wu

    1. You have access
      Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial
      Tianqing Chu, Jun Lu, Minghong Bi, Helong Zhang, Wu Zhuang, Yan Yu, Jianhua Shi, Zhendong Chen, Xiaochun Zhang, Qisen Guo, Quan Liu, Huijuan Wu, Jian Fang, Yi Hu, Xiuwen Wang, Cuicui Han, Kai Li and Baohui Han
      Cancer Biology & Medicine August 2021, 18 (3) 816-824; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0212
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 18 (3)
Cancer Biology & Medicine
Vol. 18, Issue 3
1 Aug 2021
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire